Back
Genpact Vs. Corcept Therapeutics Industry Stock Comparison
Buy
56
G
Genpact
Last Price:
$47.59
Seasonality Move:
6.37%
Sell
39
CORT
Corcept Therapeutics
Last Price:
$62.21
Seasonality Move:
2.94%
Sell
39
Corcept Therapeutics (CORT)
is a Sell
Is Corcept Therapeutics a Buy, Sell or Hold?
-
The current Corcept Therapeutics [CORT] share price is $62.24. The Score for CORT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
CORT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
G Stock Price Chart
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $62.24The current trend is moderately bullish and CORT is experiencing selling pressure, which indicates risk of future bearish movement.
G Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.83 | Sell |
Relative Strength Index (14 RSI): | 43.56 | Sell |
Chaikin Money Flow: | -387286 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.41 - 50.65) | Sell |
Bollinger Bands (100): | (44.15 - 51.53) | Sell |
CORT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 10.87 | Buy |
Relative Strength Index (14 RSI): | 45.43 | Sell |
Chaikin Money Flow: | -1300725 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (54.28 - 81.16) | Sell |
Bollinger Bands (100): | (51.56 - 70.54) | Buy |
G Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.31 | Buy |
20-day SMA: | 48.71 | Sell |
50-day SMA: | 50.8 | Sell |
200-day SMA: | 42.68 | Buy |
8-day EMA: | 47.72 | Sell |
20-day EMA: | 48.49 | Sell |
50-day EMA: | 48.97 | Sell |
200-day EMA: | 44.18 | Buy |
CORT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 67.96 | Sell |
20-day SMA: | 70.35 | Sell |
50-day SMA: | 65.64 | Sell |
200-day SMA: | 50.63 | Buy |
8-day EMA: | 67.47 | Sell |
20-day EMA: | 61.32 | Buy |
50-day EMA: | 39.81 | Buy |
200-day EMA: | 13.23 | Buy |
Genpact Earnings Growth & G Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.31 per share, and an increase next year of $0.35 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.29 per share, and an increase next year of $1.64 per share.
Genpact Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corcept Therapeutics Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |